Cargando…

Granulocyte‐Macrophage Colony‐stimulating Factor Augments Lymphokine‐activated Killer Activity from Pleural Cavity Mononuclear Cells of Lung Cancer Patients without Malignant Effusion

The role of recombinant granulocyte‐macrophage colony‐stimulating factor (GM‐CSF) in augmentation of lymphokine‐activated killer (LAK) cell induction by interleukin‐2 (IL‐2) from pleural cavity mononuclear cells (PCMNCs) was examined in sixteen patients with resectable primary lung cancer not associ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takahashi, Keiji, Sone, Saburo, Saito, Seiya, Kamamura, Yoshitaka, Uyama, Tadashi, Ogura, Takeshi, Monden, Yasumasa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1995
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920930/ https://www.ncbi.nlm.nih.gov/pubmed/7591964 http://dx.doi.org/10.1111/j.1349-7006.1995.tb03097.x

Ejemplares similares

Lymphokine‐activated Killer Induction and Its Regulation by Macrophages in Malignant Pleural Effusions
por: Yanagawa, Hiroaki, et al.
Publicado: (1989)

Killing of Alveolar Macrophages and of Monocytes that Have Responded to Granulocyte‐Macrophage Colony‐stimulating Factor by Human Lymphokine‐activated Killer Cells
por: Sone, Saburo, et al.
Publicado: (1989)

Antitumour potential of pleural cavity macrophages in lung cancer patients without malignant effusion.
por: Kimura, S., et al.
Publicado: (1989)

Natural killer and lymphokine activated killer cell functions in Hodgkin's disease.
por: Rajaram, N., et al.
Publicado: (1990)

Enhanced lymphokine-activated killer cell activity by an immunomodulator, Roquinimex.
por: Vaz, F., et al.
Publicado: (1995)

Lymphokine-activated killer cells. Analysis of progenitors and effectors
Publicado: (1986)

Characterization of Transendothelial Migratory Lymphokine‐activated Killer Cells
por: Nakano, Koji, et al.
Publicado: (1996)

Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells
Publicado: (1983)

Induction of lymphokine-activated killer-like cells by cancer chemotherapy
Publicado: (1988)

Establishment of Mouse Lymphokine‐activated Killer Cell Clones and Their Properties
por: Kato, Kazunori, et al.
Publicado: (1991)

The Heterogeneity of Target Recognition by Lymphokine‐activated Killer Precursor Cells
por: Ibayashi, Yukihiro, et al.
Publicado: (1990)

Human Alveolar Macrophages Augment Natural Killer Cell Stimulatory Factor (Interleukin‐12)‐inducible Killer Activity from Autologous Blood Lymphocytes
por: Haku, Takashi, et al.
Publicado: (1995)

Lymphokine-activated killer cells in rats. III. A simple method for the purification of large granular lymphocytes and their rapid expansion and conversion into lymphokine-activated killer cells
Publicado: (1988)

Contribution of immature granulocyte level to diagnosis in pleural effusion
por: Kozanlı, Fatoş, et al.
Publicado: (2022)

Interleukin 5 enhances interleukin 2-mediated lymphokine-activated killer activity
Publicado: (1989)

Immune activation by combination human lymphokine-activated killer and dendritic cell therapy
por: West, E J, et al.
Publicado: (2011)

IMMUNOTHERAPY OF SOLID TOMOR BY INTRATUMORAL INFUSION OF LYMPHOKINE‐ACTIVATED KILLER CELLS
por: Yamaki, Toshiaki, et al.
Publicado: (1988)

Inhibition by Fibrin Coagulation of Lung Cancer Cell Destruction by Human Interleukin‐2‐activated Killer Cells
por: Atagi, Shinji, et al.
Publicado: (1992)

Enhancement of Therapeutic Effect of Interleukin‐2 on Spontaneous Pulmonary Metastases of Lewis Lung Carcinoma by Killer Helper Factor Associated with Increased Induction of Killer Activity
por: Fukuta, Katsuyuki, et al.
Publicado: (1989)

Accumulation of adoptively transferred adherent, lymphokine-activated killer cells in murine metastases
Publicado: (1991)

Enhancing Effect of Pokeweed Mitogen on the Proliferation and the Cytotoxicity of Lymphokine‐activated Killer Cells
por: Kimoto, Yasuhiko, et al.
Publicado: (1992)

Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis
Publicado: (1986)

Human lymphokine-activated killer cells are cytotoxic against cells infected with Toxoplasma gondii
Publicado: (1992)

Influence of transfusion of lymphokine-activated T killer cells on inflammatory responses in dogs after laparotomy
por: MIE, Keiichiro, et al.
Publicado: (2016)

Generation and Characterization of Lymphokine‐activated Killer Cells against Fresh Human Leukemia Cells
por: Tahara, Tohru, et al.
Publicado: (1988)

Two Populations of Mouse Lymphokine‐activated Killer Cells Separated by Use of Soybean Agglutinin
por: Takano, Mariko, et al.
Publicado: (1989)

Usefulness of Lymphokine‐activated Killer Cells Generated from Bone Marrow Mononuclear Cells for the Purging of Residual Tumor Cells in Peripheral Blood Stem Cell Graft
por: Komatsu, Fumio, et al.
Publicado: (1996)

Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells
Publicado: (1989)

Reinforced Cytotoxicity of Lymphokine‐activated Killer Cells toward Glioma Cells by Transfection of the Killer Cells with the γ‐Interferon Gene
por: Mizuno, Masaaki, et al.
Publicado: (1995)

Lymphokine-activated killer cell susceptibility and adhesion molecule expression of multidrug resistant breast carcinoma
por: Savas, Burhan, et al.
Publicado: (2006)

Lysis of allogeneic and autologous melanoma cells by IL-7-induced lymphokine-activated killer cells.
por: Böhm, M., et al.
Publicado: (1994)

T Cell Receptor‐independent Cell‐mediated Cytotoxicity by Nude Mouse Lymphokine‐activated Killer Cells
por: Nishimura, Takashi, et al.
Publicado: (1991)

Lymphokine-activated killer cell transplantation after anti-cancer treatment in two aged cats
por: Maeta, Noritaka, et al.
Publicado: (2019)

Oxidized-Desialylated Low-Density Lipoprotein Inhibits the Antitumor Functions of Lymphokine Activated Killer Cells
por: Aguilar Díaz de león, Jesús S, et al.
Publicado: (2021)

Mechanisms of selective killing of neuroblastoma cells by natural killer cells and lymphokine activated killer cells. Potential for residual disease eradication.
por: Foreman, N. K., et al.
Publicado: (1993)

Monoclonal antibody targeting of mononuclear cell chemokines driving malignant pleural effusion
por: Marazioti, Antonia, et al.
Publicado: (2014)

Diagnostic Accuracy of Pleural Effusion Mononuclear Cells/Leukocyte Ratio in Tuberculous Pleurisy
por: Lei, Xiaoli, et al.
Publicado: (2021)

Efficacy of chemoimmunotherapy with cyclophosphamide, interleukin-2 and lymphokine activated killer cells in an intraperitoneal murine tumour model.
por: Eggermont, A. M., et al.
Publicado: (1988)

Generation of adherent lymphokine activated killer (A-LAK) cells from patients with acute myelogenous leukaemia.
por: Sedlmayr, P., et al.
Publicado: (1992)

Expression of Membrane‐associated Lymphotoxin/Tumor Necrosis Factor‐β on Human Lymphokine‐activated Killer Cells
por: Abe, Yasuhito, et al.
Publicado: (1991)

Cannot write session to /tmp/vufind_sessions/sess_c5fts0p9jh93jh9fvbj8ff4qum